Qiagen N.V. has grown revenue −0.81% a year over three years and 2.3% a year over five, with earnings per share compounding at 1.8%. Revenue growth, 3-year annual rate: −0.81% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +2.3%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +1.8%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 18, FY2008 to FY2025, as filed.

QGENQiagen N.V.

Healthcare

$45.40-1.2% 1Y

$45.40

$32.6352 weeks$55.66

Is it growing?

Mixed

Neither accelerating nor breaking down: earnings up +424% year on year, but operating margin narrowing (−5.7 points).

1 good, 1 to watch, 1 neutral

Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Earnings trend+424% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−5.7 points operating

Trailing-twelve-month operating margin, 22.3% now against 28.0% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is QGEN growing?

Qiagen N.V. has grown revenue −0.81% a year over three years and 2.3% a year over five, with earnings per share compounding at 1.8%.

−0.81%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · shrinking · compounded from fiscal years as filed

Revenue growth, 5-year rate: +2.3%
Revenue growth, 5-year rate · −0.81% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +1.8%
Earnings per share, 3-year rate · revenue −0.81% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed